News
- Author:
- Neil Osterweil
Publish date: March 7, 2018
The researchers called for greater awareness of the potential for fungal infection in ibrutinib-treated patients.
News
- Author:
- Neil Osterweil
Publish date: March 7, 2018
Home HIV diagnosis coupled to same-day ART initiation may help rural patients.
News
- Author:
- Neil Osterweil
Publish date: March 5, 2018
New, shorter TB regimen is effective and could up adherence in HIV-positive individuals.
News
- Author:
- Neil Osterweil
Publish date: March 5, 2018
Although about two-thirds of patients had treatment-related adverse events, most experienced only mild or moderate ones.
News
- Author:
- Neil Osterweil
Publish date: March 2, 2018
An analysis of cancer registry data suggests that surgery and external beam radiotherapy plus brachytherapy have similar survival outcomes in patie...
News
- Author:
- Neil Osterweil
Publish date: March 1, 2018
The combination of selinexor with dexamethasone looks most promising for this hard-to-treat population.
News
- Author:
- Neil Osterweil
Publish date: February 28, 2018
LA JOLLA, CALIF. – The study mines data from the SEER-18 database.
News
- Author:
- Neil Osterweil
Publish date: February 21, 2018
LA JOLLA, CALIF. – The phase 1 trial is testing the use of a CD25 monoclonal antibody for achieving long-term remission in PTCL.
News
- Author:
- Neil Osterweil
Publish date: February 16, 2018
At a median of 20.4 months of follow-up, the overall response rate was 73% in an open-label phase 1b dose-finding trial and expansion in 52 patient...
News
- Author:
- Neil Osterweil
Publish date: February 16, 2018
The results come from a phase 3 randomized trial of patients with newly diagnosed multiple myeloma with one or more lytic bone lesions.
News
- Author:
- Neil Osterweil
Publish date: February 14, 2018
LA JOLLA, CALIF. – Subtype and timing matter when considering the best bridge to transplant.
News
- Author:
- Neil Osterweil
Publish date: February 9, 2018
In 2017, the FDA approved 17 agents for new or expanded indications for hematologic malignancies, including one agent for anaplastic large cell lym...
News
- Author:
- Neil Osterweil
Publish date: February 9, 2018
LA JOLLA, CALIF. – Three new agents are in the pipeline for T-cell lymphoma.
News
- Author:
- Neil Osterweil
Publish date: February 1, 2018
Experimental inhibition of the vasoactive intestinal peptide–CRTH2 axis could reduce the hallmark symptoms of EoE.
News
- Author:
- Neil Osterweil
Publish date: January 16, 2018
Of 60 patients with desmoplastic melanoma treated with checkpoint inhibitors and followed for a median of 22 months, 42 had an objective response, ...
